InfuSystem Holdings Inc., also known as INFU, is a leading provider of infusion pumps and related services in the United States and Canada. Founded in 2005, the company is headquartered in Rochester Hills, Michigan, US. INFU is publicly traded on the NYSE under the ticker symbol "INFU". It provides cost-effective solutions to hospitals, oncology practices, and other healthcare providers, while ensuring high-quality patient care and improved clinical outcomes.
InfuSystem's services are primarily categorized into two – Integrated Therapy Service (ITS) and Durable Medical Equipment. The ITS program provides electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of a various diseases including colorectal cancer, hepatobiliary cancers, etc. Its Durable Medical Equipment program involves the rental, sale or leasing of infusion pumps to the individuals suffering from painful conditions such as pancreatitis, abdominal pain, etc.
The company has expertise in managing thousands of pumps and millions of disposals each month, along with facilitating third-party payer billing, simplifying the complexities of therapy regimens while maximizing revenue. InfuSystem works closely with healthcare practitioners, patients, and caregivers to deliver high-quality care and ensure customer satisfaction.
InfuSystem's proprietary suite of technology solutions, including InfuSystem Mobile, provides a platform for tracking infusion pumps, improved billing accuracy, enhanced practicality, and clinical education. Their innovative smart pump technology enables seamless integration of medical devices with information systems to improve safety and efficiency.
Since its inception, InfuSystem has been known for its commitment to improving patient outcomes. The company continually invests in innovation and technology to enhance its product suite and expand its service offerings. This dedication to better patient care and hospital productivity has positioned InfuSystem as a reliable and respected name in the healthcare sector.
Under the leadership of CEO Richard DiIorio, who took over in 2017, InfuSystem has shown continuous growth, with impressive financial results. The company has robust plans for future growth, building on a solid foundation of quality service, innovation, and a commitment to improving patient care delivery. However, like other healthcare providers, InfuSystem is grappling with the effects of the COVID-19 pandemic, though its diversified revenue stream and innovative technological solutions are expected to help it navigate these challenges effectively.
In conclusion, InfuSystem Holdings, Inc, through its innovative service offerings and commitment to quality patient care, sets itself apart in the healthcare sector.